Trading Ideas NKGen Biotech, Inc.

Equities

End-of-day quote Nasdaq Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
1.67 ^USD	+6.37%		+17.61%	-39.27%

05-23	NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology Annual Meeting	CI
05-20	NKGen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

No results for this search